Marais AD - Search Results

1

Homozygous familial hypercholesterolemia and its management.

Marais AD, Firth JC, Blom DJ. Marais AD, et al. Semin Vasc Med. 2004 Feb;4(1):43-50. doi: 10.1055/s-2004-822985. Semin Vasc Med. 2004. PMID: 15199432 Review.

2

Using changes in attributable risk to predict long-term efficacy of simvastatin treatment.

Vermaak WJ, Ubbink JB, Ungerer JP, Marais AD, Firth J, Van Lathem JM, Becker PJ. Vermaak WJ, et al. Among authors: marais ad. Clin Chem. 1992 Oct;38(10):2033-7. Clin Chem. 1992. PMID: 1394987

3

Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: a comparison of two geographical areas.

Graadt van Roggen F, van der Westhuyzen DR, Marais AD, Gevers W, Coetzee GA. Graadt van Roggen F, et al. Among authors: marais ad. Hum Genet. 1991 Dec;88(2):204-8. doi: 10.1007/BF00206073. Hum Genet. 1991. PMID: 1757095

4

Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.

Berger GM, Firth JC, Jacobs P, Wood L, Marais AD, Horak A. Berger GM, et al. Among authors: marais ad. Am J Med. 1990 Feb;88(2):94-100. doi: 10.1016/0002-9343(90)90455-m. Am J Med. 1990. PMID: 2105647

5

Fatal outcome of homozygous familial hypercholesterolaemia in a black patient. A case report.

Marais AD, Firth JC, Rose AG, Berger GM. Marais AD, et al. S Afr Med J. 1990 Jun 2;77(11):588-90. S Afr Med J. 1990. PMID: 2345887

6

New drugs for treating hypercholesterolemia and other hyperlipidaemias--the HMG CoA reductase inhibitors.

Berger GM, Marais AD, Firth JC. Berger GM, et al. Among authors: marais ad. S Afr Med J. 1990 Jan 20;77(2):57-9. S Afr Med J. 1990. PMID: 2404345 Review. No abstract available.

7

FH Afrikaner-3 LDL receptor mutation results in defective LDL receptors and causes a mild form of familial hypercholesterolemia.

Graadt van Roggen JF, van der Westhuyzen DR, Coetzee GA, Marais AD, Steyn K, Langenhoven E, Kotze MJ. Graadt van Roggen JF, et al. Among authors: marais ad. Arterioscler Thromb Vasc Biol. 1995 Jun;15(6):765-72. doi: 10.1161/01.atv.15.6.765. Arterioscler Thromb Vasc Biol. 1995. PMID: 7773731

8

Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations.

Kotze MJ, De Villiers WJ, Steyn K, Kriek JA, Marais AD, Langenhoven E, Herbert JS, Graadt Van Roggen JF, Van der Westhuyzen DR, Coetzee GA. Kotze MJ, et al. Among authors: marais ad. Arterioscler Thromb. 1993 Oct;13(10):1460-8. doi: 10.1161/01.atv.13.10.1460. Arterioscler Thromb. 1993. PMID: 8399083

9

Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.

Naoumova RP, Marais AD, Mountney J, Firth JC, Rendell NB, Taylor GW, Thompson GR. Naoumova RP, et al. Among authors: marais ad. Atherosclerosis. 1996 Jan 26;119(2):203-13. doi: 10.1016/0021-9150(95)05649-1. Atherosclerosis. 1996. PMID: 8808497

10

Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.

Marais AD, Firth JC, Bateman ME, Byrnes P, Martens C, Mountney J. Marais AD, et al. Arterioscler Thromb Vasc Biol. 1997 Aug;17(8):1527-31. doi: 10.1161/01.atv.17.8.1527. Arterioscler Thromb Vasc Biol. 1997. PMID: 9301631 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters